^{Published on 2024-10-28 03:38:49 - WOPRAI, Robert Driscoll}

Robert Driscoll of Wedbush, Reiterated "Tango Therapeutics, Inc." (TNGX) at Buy and Held Target at $18 on, May 10th, 2023.

Robert has made no other calls on TNGX in the last 4 months.

There is 1 other peer that has a rating on TNGX. Out of the 1 peers that are also analyzing TNGX, 0 agree with Robert's Rating of Hold.

This is the rating of the analyst that currently disagrees with Robert

Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $11 on, Tuesday, March 28th, 2023